Hyflux disputes several statements by suitor Utico
Singapore
DISTRESSED water-treatment company Hyflux has disputed several statements made by its Emirati suitor Utico in a letter published over the weekend, including that various groups of creditors are working with Hyflux and Utico in tandem, and that Utico is the only potential investor with a firm binding offer.
Mainboard-listed Hyflux, in a regulatory statement to the Singapore Exchange on Tuesday, publicly disagreed with Utico's version of events related to its restructuring efforts.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance
Suntec Reit Q1 DPU down 13% to S$0.01511 in absence of capital distribution